Circulating DNA in patients undergoing loco-regional treatment of colorectal cancer metastases: a systematic review and meta-analysis.
Louise Bach CallesenTana TakacovaJulian HamfjordFlorian WürschmidtKarl J OldhaferRoland BrüningDirk ArnoldKaren-Lise G SpindlerPublished in: Therapeutic advances in medical oncology (2022)
Measurements of circulating DNA can be valuable when selecting and monitoring patients undergoing loco-regional treatment of CRC metastases. Studies designed to investigate the true clinical utility of circulating DNA in the context of various ablation modalities are warranted.The review has been registered at PROSPERO (ID: CRD42022320032).